Potential of oligonucleotide- and protein/peptide-based therapeutics in the management of toxicant/stressor-induced diseases.

Autor: Sadeghian I; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Biotechnology Incubator, Shiraz University of Medical Sciences, Shiraz, Iran., Akbarpour M; Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Chafjiri FMA; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Chafjiri PMA; School of Public Health, Boston University, Boston, MA, USA., Heidari R; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Morowvat MH; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran., Sadeghian R; Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Raee MJ; Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Iran., Negahdaripour M; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. negahdaripour@sums.ac.ir.; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. negahdaripour@sums.ac.ir.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Mar; Vol. 397 (3), pp. 1275-1310. Date of Electronic Publication: 2023 Sep 09.